PE Partners Talk Carveouts and Growth Opportunities
Related Stories
May 17, 2021
May 7, 2021
May 5, 2021
Identifying carveout opportunities and exit paths are some of the many topics discussed at our panel with leading private equity founding partners:
R. David Andrews, founder & CEO of
Gryphon Investors;
Edgewater Capital; and
Francisco Partners; and moderated by editor-in-chief
Mary Kathleen Flynn. The panel took place as part of
Mergers & Acquisitions’ The Best in M&A Speak virtual event, where we announced the winners of the
2021 Top 10 Middle-Market Deals of the Year.
More From Honors
Elastic (NYSE: ESTC) (Elastic), the company behind Elasticsearch and the Elastic Stack, announced that its presentation time at the virtual Goldman Sachs
Share this article
Share this article
ORANGE, Calif., Jan. 7, 2021 /PRNewswire/ Plethora Businesses, an M&A advisory firm headquartered in Orange, California, is pleased to announce the closing of three transactions in December, 2020. Plethora served as the exclusive sell-side advisor in each deal. The last two weeks of December alone were quite active for our sell-side department at nearly $100M in transaction value. With 2020 squarely in our rear view mirror, we re looking forward to 2021 and what the year will bring for our firm and the broader M&A community, said George Lanza, President.
Edgewater Capital Partners Invests in Naprotek
Naprotek, based in San Jose, California, is an electronic manufacturing services company that provides partners with OEMs and next-gen technology leaders to bring concept and products to market. Their core services are quick turn printed circuit board assembly ( PCBA ), new product introduction ( NPI ), design for manufacturability, system
Naprotek, LLC, a provider of electronic manufacturing services, has been purchased by Edgewater Capital Partners.
“Few PCBA businesses are so consistent in their strategy as Naprotek,” commented Pete Ostergard, Partner at Edgewater Capital. “The company is unwavering in its focus on hi-rel applications that demand speed and complexity. We are excited to partner with the Naprotek team to expand capabilities in support of this strategy and build on its heritage of outstanding customer service and product quality.”
Chris Springer, Operating Partner at Edgewater Capital, added, “Naprotek’s service model is really unique in the electronics value chain. With an organization that is purpose-built for agility and technical complexity, it is no wonder that customers trust Naprotek with their Hi-Rel applications.”
The Unsung Heroes Of Drug Development: Small Pharma-Service Entrepreneurs Make A Big Impact
By Brian Scanlan, operating partner – Life Science Practice, Edgewater Capital Partners
Over the past decade, the consolidation activity in the outsourced pharma services world has left a giant chasm between the global giants and the small entrepreneurial service providers. Transaction activity has been strong, with over 400 deals in past five years alone.
1 In the U.S., the large global CDMOs have acquired a majority of the remaining independent midsize players, leaving many of my colleagues challenged to name more than a handful of truly independent midsize pharma services firms remaining in the U.S. today. With so few mid-tier players left, you might be asking, “where have all the entrepreneurs gone?” It seems those technical entrepreneurs from decades past who built the thriving outsourced pharma services industry we see today have themselves been merged into retirement as their o